Adrianol 0,5 mg/0,5 mg/ml picături nazale, soluţie Moldavia - rumano - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

adrianol 0,5 mg/0,5 mg/ml picături nazale, soluţie

fhi "zdravlje" ad - phenylephrinum + lerimazolinum - picături nazale, soluţie - 0,5 mg/0,5 mg/ml

Adrianol 1 mg/1,5 mg/ml picături nazale, soluţie Moldavia - rumano - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

adrianol 1 mg/1,5 mg/ml picături nazale, soluţie

fhi "zdravlje" ad - phenylephrinum + lerimazolinum - picături nazale, soluţie - 1 mg/1,5 mg/ml

Sibnayal Unión Europea - rumano - EMA (European Medicines Agency)

sibnayal

advicenne s.a. - potassium citrate monohydrated, potassium hydrogen carbonate - acidosis, renal tubular - mineral supplements - sibnayal is indicated for the treatment of distal renal tubular acidosis (drta) in adults, adolescents and children aged one year and older.

ADVIL 200 mg Rumanía - rumano - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

advil 200 mg

haleon italy manufacturing s.r.l. - italia - ibuprofenum - draj. - 200mg - antiinflamatoare si antireumatice nesteroidiene derivati de acid propionic

ADVIL ULTRA 200 mg Rumanía - rumano - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

advil ultra 200 mg

haleon italy manufacturing s.r.l. - italia - ibuprofenum - caps. moi - 200mg - antiinflamatoare si antireumatice nesteroidiene derivati de acid propionic

NEOLIN Rumanía - rumano - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

neolin

bio eel srl - romania - combinatii (acid acetylsalicylicum+paracetamolum+codeinum) - compr. - 300mg/250mg/12mg - alte analgezice si antipiretice acid salicilic si derivati

Zolsketil pegylated liposomal Unión Europea - rumano - EMA (European Medicines Agency)

zolsketil pegylated liposomal

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.